During the last three months, 5 analysts shared their evaluations of Repligen (NASDAQ:RGEN), revealing diverse outlooks from bullish to bearish. The following table encapsulates their recent ratings, ...

Repligen Corp (NASDAQ:RGEN) released on Tuesday third-quarter adjusted EPS of 43 cents, up from 23 cents a year ago, beating the consensus of 33 cents. The bioprocessing technology reported sales of ...

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same ...

We recently published Top 10 Stock Recommendations You Can’t Miss Amid Growing AI Bubble Fears. Repligen Corporation (NASDAQ:RGEN) is one of the top recommended stocks. Dan Veru, Palisade Capital ...

If you are wondering whether Repligen at around US$119.99 is a bargain or still looks expensive, you are not alone. That is exactly what this article aims to unpack for you. Over the past week the ...

Providing a diverse range of perspectives from bullish to bearish, 8 analysts have published ratings on Repligen (NASDAQ:RGEN) in the last three months. The following table encapsulates their recent ...

In the preceding three months, 5 analysts have released ratings for Repligen (NASDAQ:RGEN), presenting a wide array of perspectives from bullish to bearish. The table below summarizes their recent ...

We recently published a list of Top 10 Stocks to Buy According to 12 West Capital Management. In this article, we are going to take a look at where Repligen Corporation (NASDAQ:RGEN) stands against ...

Repligen (NASDAQ:RGEN – Get Free Report) was upgraded by StockNews.com from a “sell” rating to a “hold” rating in a research note issued to investors on Monday. A number of other research analysts ...